Nasdaq - Delayed Quote USD

Driehaus Micro Cap Growth Fund (DMCRX)

15.72 +0.16 (+1.03%)
As of 8:05 AM EST. Market Open.

Top 10 Holdings (19.56% of Total Assets)

SymbolCompany% Assets
CRNX
Crinetics Pharmaceuticals, Inc. 3.16%
TMDX
TransMedics Group, Inc. 2.51%
MOD
Modine Manufacturing Company 2.32%
ADMA
ADMA Biologics, Inc. 2.04%
ALKT
Alkami Technology, Inc. 1.74%
XENE
Xenon Pharmaceuticals Inc. 1.69%
LRN
Stride, Inc. 1.60%
FTAI
FTAI Aviation Ltd. 1.52%
ASPN
Aspen Aerogels, Inc. 1.51%
ARLO
Arlo Technologies, Inc. 1.48%

Sector Weightings

Overall Portfolio Composition (%)

Cash 0.43%
Stocks 99.57%
Bonds 0.00%
Others 0.00%
Preferred 0.00%
Convertible 0.00%

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

Equity Holdings

Average DMCRX Category Average
Price/Earnings 0 34.63
Price/Book 0.25 5.39
Price/Sales 0.42 3.86
Price/Cashflow 0.05 22.99
Median Market Cap 2,327.61 5,964.6
3 Year Earnings Growth 0 15.48

Bond Holdings

Performance & Risk

YTD Return 34.14%
5y Average Return 20.68%
Rank in Category (ytd) 5
% Rank in Category (ytd) --
Beta (5Y Monthly) 1.09
Morningstar Risk Rating

Fund Overview

Category Small Growth
Fund Family Driehaus
Net Assets 285.79M
YTD Return 24.14%
Yield 0.70%
Morningstar Rating
Inception Date Nov 18, 2013

Fund Summary

The fund uses a growth style of investment in equity securities, including common stocks and other equity securities of issuers. Under normal market conditions, it invests at least 80% of its net assets (plus the amount of borrowings for investment purposes) in the equity securities of U.S. micro-capitalization ("micro-cap") companies. For purposes of the fund, the investment adviser considers a company to be a micro-cap company if it is within the same market capitalization range at the time of investment as those included in the Russell Microcap? Growth Index.

Related Tickers